GlassScriptPhysician profile
Dan Georgescu
NPI 1598936924
$1,682.41
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $85.22 · 2021: $438 · 2022: $322 · 2023: $255 · 2024: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $511.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $908.86 | 2021-2023 | Tepezza |
| Merz North America, INC. | $410.82 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $118.58 | 2024 | |
| Johnson & Johnson Surgical Vision, INC. | $94.29 | 2024 | Tecnis Iol |
| Abbvie INC. | $87.45 | 2022-2023 | |
| Galderma Laboratories, L.P. | $28.66 | 2024 | |
| Organogenesis INC. | $18.32 | 2023 | Puraply |
| Amgen INC. | $15.43 | 2024 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Georgescu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.